De-escalation Strategy
Showing 1 - 25 of >10,000
Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)
Recruiting
- Breast Cancer
- axillary surgery de-escalation after NAT
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 13, 2023
Acute Myocardial Infarction, Ticagrelor Trial in Busan (Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor
- Clopidogrel 75 mg
- +2 more
-
Busan, Korea, Republic ofDongA University Hospital
Jan 14, 2022
Acute Myocardial Infarction Trial in Busan (Ticagrelor 90mg, Ticagrelor 60/45mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor 90mg
- Ticagrelor 60/45mg
-
Busan, Korea, Republic ofDongA University Hospital
Feb 11, 2021
Acute Coronary Syndrome, Coronary Artery Disease Trial in Seoul (De-escalation Treatment Strategy of dual antiplatelet therapy)
Recruiting
- Acute Coronary Syndrome
- Coronary Artery Disease
- De-escalation Treatment Strategy of dual antiplatelet therapy
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 7, 2021
Coronary Stenoses Trial in Korea, Republic of (Tailored antithrombotic strategy, Conventional antithrombotic strategy)
Recruiting
- Coronary Stenoses
- Tailored antithrombotic strategy
- Conventional antithrombotic strategy
-
Anyang, Korea, Republic of
- +19 more
Jul 19, 2021
Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine
Not yet recruiting
- Breast Cancer
- Standard of care administration of Endocrine therapy
- Dose-frequency escalation administration of Endocrine therapy
- (no location specified)
Feb 22, 2023
![](/image/sponsor/azienda_ospedaliera_universitaria_policlinico_"g_martino")
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- DE-HyART
- +3 more
-
Delhi, IndiaRajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023
Liver Cancer, Hepatocellular Carcinoma Trial (Regorafenib Oral Product)
Not yet recruiting
- Liver Cancer
- Hepatocellular Carcinoma
- Regorafenib Oral Product
- (no location specified)
Nov 17, 2022
Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)
Not yet recruiting
- Coronary Artery Disease
- aspirin plus clopidogrel
- prasugrel or ticagrelor
-
Jacksonville, FloridaUniversity of Florida
Jan 4, 2023
Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)
Not yet recruiting
- Atopic Dermatitis
- Dupilumab - Discontinuation
- +2 more
- (no location specified)
Nov 2, 2023
IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- Adalimumab
-
Gent, Belgium
- +6 more
May 17, 2022
Dementia Trial in Hong Kong (Individualized music playlist, Preferred music, Usual care)
Not yet recruiting
- Dementia
- Individualized music playlist
- +2 more
-
Hong Kong, Hong KongSchool of Nursing, The Hong Kong Polytechnic University
Oct 26, 2023
Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual
Recruiting
- Coronary Artery Disease
- +6 more
- De-escalated Dual Antiplatelet Therapy
- Dual Antiplatelet Therapy
-
Beijing, ChinaFuwai Hospital
Dec 13, 2022
Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina Trial
Not yet recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- +2 more
- De-escalation to ticagrelor 60 mg at day 30
- +3 more
-
Bydgoszcz, Kujawsko-pomorskie, PolandDepartment of Cardiology, Dr. A. Jurasz University Hospital, Col
Mar 9, 2023
Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,
Recruiting
- Oropharyngeal Cancer
- Squamous Cell Carcinoma of the Oropharynx
- Surgery
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
May 30, 2023
Ventilator Associated Pneumonia Trial (cotrimoxazole, standard antibiotic therapy)
Not yet recruiting
- Ventilator Associated Pneumonia
- cotrimoxazole
- standard antibiotic therapy
- (no location specified)
Jan 23, 2023
Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab
Not yet recruiting
- Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jun 27, 2023
Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)
Not yet recruiting
- Prostate Adenocarcinoma
- De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
- (no location specified)
Jan 23, 2023
Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)
Recruiting
- Head and Neck Carcinoma
- Elective nodal de-escalation arm
-
Cairo, EgyptNational Cancer Institute
Dec 6, 2022
Prostate Cancer Trial in Toronto (Image-guided Radiotherapy)
Recruiting
- Prostate Cancer
- Image-guided Radiotherapy
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 6, 2022
Acute Coronary Syndrome Trial in Muncie (MT1002 for Injection)
Recruiting
- Acute Coronary Syndrome
- MT1002 for Injection
-
Muncie, IndianaBruce Graham
Jan 23, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Belgium (Dose de-escalation and / or Volume de-escalation)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Dose de-escalation and / or Volume de-escalation
-
Brussel, Belgium
- +3 more
Jan 25, 2022
Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)
Recruiting
- Oropharyngeal Cancer
- Toxicities reduced treatment
- Conventional treatment
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
Atrial Fibrillation Trial in Sofia (Cardioversion with a pulsed biphasic waveform, Cardioversion with a biphasic truncated
Recruiting
- Atrial Fibrillation
- Cardioversion with a pulsed biphasic waveform
- Cardioversion with a biphasic truncated exponential waveform
-
Sofia, BulgariaUniversity National Heart Hospital
Jul 20, 2022